[Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig
A
A
Abteilung Angiologie, Medizinische Hochschule Hannover.
Caspary
L
L
Alexander
K
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000527:Alprostadil / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000188:drug therapy*; D001785:Blood Gas Monitoring, Transcutaneous; D003925:Diabetic Angiopathies / Q000097:blood / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008833:Microcirculation / Q000187:drug effects / Q000503:physiopathology; D008875:Middle Aged; D012867:Skin / Q000098:blood supply
D000527:Alprostadil
Doppelblinde placebokontrollierte Studie zum Verhalten des tcPO2 während intravenöser Infusion von Prostaglandin E1 bei Patienten mit schwerer AVK.